Theramex receives recommendation for YSELTY in Scotland
November 11, 2024Research and Development Pain, Reproductive health, appproval, tumours, women's health
Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …
CMS commences formal review for Topical Oxygen Therapy coverage
November 11, 2024Wound Healing, topical oxygen therapy, wound care
11 November 2024 AOTI, INC. (AIM: AOTI), a medical technology group focussed on the durable healing of wounds and prevention …
Johnson & Johnson receive MHRA approval for BALVERSA
November 8, 2024Research and Development J&J Innovative Medicine, Oncology, Urology, bladder cancer
BALVERSA (erdafitinib) has been granted marketing approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment …
SolasCure partners with US Army for better wound care technology
November 6, 2024Research and Development Dressings, hosiery & appliances, Solascare, US army, wound care, wound gel
SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …
NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink
November 5, 2024Research and Development NorthWest Ehealth, clinical trials
The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies …
FlyPharma Vienna 2024: An Event to Remember!
November 4, 2024Corporate, FlyPharma 2024, Samedan, event
Samedan announces that their 2024 FlyPharma Conference, held in Office Park 4, Vienna AirportCity, Austria, has officially concluded! As a …
Valneva Scotland supports local cancer charity Team Jak Foundation
October 31, 2024Support Services Oncology, Scotland, Valneva Scotland, cancer charity, paediarics, vaccines
Valneva Scotland, the country’s largest vaccine producer, has partnered with local West Lothian-headquartered charity, Team Jak, helping towards the organisation’s …
University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma
October 30, 2024Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors
Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …
Darrin Schellin appointed new CEO at Pharma Tech Industries
October 30, 2024CEO, Pharma Tech Industries, manufacturing and packaging, pharmaceutical
Pharma Tech Industries, a pharmaceutical manufacturing and packaging solutions contractor for wellness products and medical devices, has announced the appointment …
HIV vaccine candidate successfully optimised for industrial production
October 30, 2024Research and Development HIV, HIV/AIDS, Naobios, Sumagen, Vaccine, agreement
Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise …
Chiesi announces phase 3 results from enzyme-replacement study
October 29, 2024Research and Development Internal Medicine, Rare Diseases, chiesi Global rare diseases, clinical trials, pharma, rare diseases
Chiesi Global Rare Diseases have announced the results from their BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug …
From molecule to market and beyond: Uniphar announces extended global commercialization platform
October 25, 2024CRO, UniPhar, cell and gene
22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 55 …
Shawn Cross appointed as chief financial officer for Pacira Biosciences
October 25, 2024Research and Development Pacira Biosciences
Pacira Biosciences, spcecialist in non-opioid pain therapies, has appointed Shawn Cross as their chief financial officer. In this role, Mr …
VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases
October 25, 2024Nephrology, Rare Diseases, rare kidney disease, trial
SOBI and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit …
Stelis, Strides and Steriscience merge to form new CDMO
October 22, 2024Research and Development CMDO, CPhI, Corporate, bangalore, merger
The CDMO launched earlier this year at the CPHI conference in Milan. The merger is comprised of Stelis Sciences, Strides …
Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis
October 21, 2024Research and Development CHMP, EMA, EU, Internal Medicine, gene
Wainzua (eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the European Union (EU) by the European …
Eli Lilly appoints new chief AI officer
October 17, 2024AI and ML, Corporate, Eli Lilly
Eli Lilly has announced the appointment of Thomas J Fuchs as its first chief artificial intelligence (AI) officer. Fuchs’ appointment …
FlyPharma Europe, Vienna – 23-24 October 2024 conference
October 14, 2024Conference, Corporate, flypharma, pharmaceutical
Samedan announces that on 23-24 October 2024, their FlyPharma Conference will make a welcome return to Office Park 4, Vienna …
Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study
October 3, 2024Research and Development Ferring Pharmaceuticals, Gastrointestinal tract, ulcerative colitis
1 October 2024 – Saint-Prex, Switzerland – Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world …
Strategic alliance announced between Recipharm and Exela
October 1, 2024Research and Development Corporate, Exela, Recipharm, US
Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The alliance between the two contract …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
